Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Daniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, Brian B. Godman, Ramon Goncalves Pereira & Augusto A Guerra Junior. (2022) Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions. Expert Review of Pharmacoeconomics & Outcomes Research 22:6, pages 927-939.
Read now
Read now
Daniel Resende Faleiros, Juliana Alvares-Teodoro, Everton Nunes da Silva, Brian B. Godman, Ramon Gonçalves Pereira, Eli Iola Gurgel Andrade, Francisco A. de Assis Acurcio & Augusto A. Guerra Júnior. (2022) Budget impact analysis of medicines: estimated values versus real-world evidence and the implications. Expert Review of Pharmacoeconomics & Outcomes Research 22:2, pages 271-281.
Read now
Read now
Naghmeh Foroutan, Jean-Eric Tarride, Feng Xie & Mitchell Levine. (2018) A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions. ClinicoEconomics and Outcomes Research 10, pages 821-854.
Read now
Read now
Peslie G Ngambi, Aubrey C Kalungia, Michael R Law, Francis Kalemeera, IIse Truter, Brian Godman & Derick Munkombwe. (2017) Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 459-467.
Read now
Read now
Articles from other publishers (25)
Carlos Rojas-Roque & Alfredo Palacios. (2023) A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America. Applied Health Economics and Health Policy 21:3, pages 419-440.
Crossref
Crossref
Andrew Wang, Juan Carlos Caicedo, Amit K. Mathur, Richard M. Ruiz & Elisa J. Gordon. (2023) Financial Impact of a Culturally Sensitive Hispanic Kidney Transplant Program on Increasing Living Donation. Transplantation 107:4, pages 970-980.
Crossref
Crossref
Rod Ling, Michelle Giles & Andrew Searles. (2022) Budget impact analysis of a multifaceted nurse-led intervention to reduce indwelling urinary catheter use in New South Wales Hospitals. BMC Health Services Research 22:1.
Crossref
Crossref
Olga Ivanovna Goleva & Lyubov Ivanovna Goleva. (2022) Financial Literacy and Investment in Health: Points of Intersection. Финансы и управление:4, pages 16-33.
Crossref
Crossref
Zejun Luo, Zhen Ruan, Dongning Yao, Carolina Oi Lam Ung, Yunfeng Lai & Hao Hu. (2021) Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review. Frontiers in Public Health 9.
Crossref
Crossref
Yue Ma, Yuxin Li, Aixia Ma & Hongchao Li. (2021) Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study. Frontiers in Public Health 9.
Crossref
Crossref
Michael Kossmeier, Madeleine Themanns, Lena Hatapoglu, Bernhard Kogler, Simon Keuerleber, Jutta Lichtenecker, Robert Sauermann, Anna Bucsics, Michael Freissmuth & Eva Zebedin-Brandl. (2021) Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria. Frontiers in Pharmacology 12.
Crossref
Crossref
Wânia Cristina da Silva, Brian Godman, Francisco de Assis Acúrcio, Mariângela Leal Cherchiglia, Antony Martin, Konrad Maruszczyk, Jans Bastos Izidoro, Marcos André Portella, Agner Pereira Lana, Orozimbo Henriques Campos Neto & Eli Iola Gurgel Andrade. (2021) The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil. Applied Health Economics and Health Policy 19:4, pages 557-577.
Crossref
Crossref
Fanny Monmousseau, Julien Ramillon, Sophie Dubnitskiy-Robin, Benjamin Faivre d’Arcier, Martine Le Verger, Tanguy Le Fol, Franck Bruyère, Emmanuel Rusch, Solène Brunet-Houdard & Benjamin Pradère. (2021) Relevance of Adopting a Hybrid Strategy Mixing Single-Use and Reusable Ureteroscopes for Stones Management: An Economic Study to Support the Best Strategy. Journal of Clinical Medicine 10:12, pages 2593.
Crossref
Crossref
Khadidja Abdallah, Isabelle Huys, Kathleen Claes & Steven Simoens. (2021) Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Michael Falk Hvidberg, Soeren Paaske Johnsen, Michael Davidsen & Lars Ehlers. (2019) A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in Denmark. PharmacoEconomics - Open 4:2, pages 361-380.
Crossref
Crossref
Naghmeh Foroutan, Jean-Eric Tarride, Feng Xie, Bismah Jameel, Fergal Mills & Mitchell Levine. (2020) Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines. Journal of Population Therapeutics & Clinical Pharmacology 27:1, pages e1-e24.
Crossref
Crossref
Seung-Mi Lee, Jae-Ho Jung, David Suh, Yu-Seon Jung, Seung-Lai Yoo, Dong-Won Kim, Ji-An Kim & Dong-Churl Suh. (2019) Budget Impact of Switching to Biosimilar Trastuzumab (CT-P6) for the Treatment of Breast Cancer and Gastric Cancer in 28 European Countries. BioDrugs 33:4, pages 423-436.
Crossref
Crossref
Joost W. Geenen, Cornelis Boersma, Olaf H. Klungel & Anke M. Hövels. (2019) Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study. The European Journal of Health Economics 20:6, pages 857-867.
Crossref
Crossref
Lara Benigno Porto, Ivan Ricardo Zimmermann & Luciana Ansaneli Naves. (2018) Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR. PharmacoEconomics - Open 3:2, pages 247-254.
Crossref
Crossref
Jans Bastos Izidoro, Thais Piazza, Eli Iola Gurgel Andrade & Juliana Alvares-Teodoro. (2019) Impacto orçamentário da incorporação de medicamentos para tratamento em segunda linha do edema macular diabético no SUS sob a perspectiva da Secretaria de Estado de Saúde de Minas Gerais, Brasil. Cadernos de Saúde Pública 35:8.
Crossref
Crossref
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Crossref
Salah Ghabri, Erwan Autin, Anne-Isabelle Poullié & Jean Michel Josselin. (2017) The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA). PharmacoEconomics 36:4, pages 407-417.
Crossref
Crossref
Carlos King Ho Wong, Olivia Wu & Bernard M. Y. Cheung. (2017) Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions. Applied Health Economics and Health Policy 16:1, pages 5-14.
Crossref
Crossref
Steven Simoens, Ira Jacobs, Robert Popovian, Leah Isakov & Lesley G. Shane. (2017) Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis. PharmacoEconomics 35:10, pages 1047-1062.
Crossref
Crossref
Charles C. Ezenduka, Daniel Resende Falleiros & Brian B. Godman. (2017) Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications. PharmacoEconomics - Open 1:3, pages 185-194.
Crossref
Crossref
Marina Kostić, Ljiljan Djakovic, Raša Šujić, Brian Godman & Slobodan M. Janković. (2016) Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications. Applied Health Economics and Health Policy 15:1, pages 85-93.
Crossref
Crossref
Giampiero Favato, Cristina Oliva & Emmanouil Noikokyris. (2018) OP72 Adherence Of Budget Impact Analyses To Principles Of Good Practice. International Journal of Technology Assessment in Health Care 33:S1, pages 32-33.
Crossref
Crossref
Josephine Mauskopf, Stephanie R. Earnshaw, Anita Brogan, Sorrel Wolowacz & Thor-Henrik BrodtkorbJosephine Mauskopf, Stephanie Earnshaw & Anita Brogan. 2017. Budget-Impact Analysis of Health Care Interventions. Budget-Impact Analysis of Health Care Interventions
217
224
.
Paolo Petralia, Nicolò Maria Buffi, Pasquale Cardone, Ubaldo Rosati, Paola Barabino, Luca Pio & Girolamo Mattioli. 2017. Pediatric Robotic Surgery. Pediatric Robotic Surgery
9
14
.